XOMA Royalty (XOMA) Net Margin (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Net Margin came in at 36.25% in Q1 2026, down 2293.0% year-on-year from 1.65% in Q1 2025, and up 159.97% quarter-over-quarter from 60.44% in Q4 2025.

XOMA Royalty (XOMA) Net Margin (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Net Margin across 16 years of filings, most recently posting 36.25% for Q1 2026.

  • Net Margin for Q1 2026 came in at 36.25%, down 2293.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 10.0% (up 18447.0% YoY), and the FY2025 annual result was 0.61%, down 2024.0% from the prior year.
  • Net Margin came in at 36.25% for Q1 2026 at XOMA Royalty, up from 60.44% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 6244.89% in Q3 2025 to a low of 68972.0% in Q3 2024.
  • The 5-year median for Net Margin is 417.9% (2022), against an average of 4035.36%.
  • Across the five-year window, Net Margin tumbled 6827477 bps in 2024 and surged 7521689 bps in 2025, its largest moves.
  • XOMA Royalty's Net Margin stood at 417.9% in 2022, then sank by 160 bps to 1087.51% in 2023, then jumped by 280 bps to 1957.0% in 2024, then plunged by 103 bps to 60.44% in 2025, then jumped by 160 bps to 36.25% in 2026.
  • The last three Net Margin figures came in at 36.25% (Q1 2026), 60.44% (Q4 2025), and 6244.89% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 34.53%
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - 36.25%

Historic Data

Download Data
DateValue
Mar 31, 2026 36.25%
Dec 31, 2025 -60.44%
Sep 30, 2025 6,244.89%
Jun 30, 2025 27.20%
Mar 31, 2025 59.18%
Dec 31, 2024 1,957.00%
Sep 30, 2024 -68,972.00%
Jun 30, 2024 -268.28%
Mar 31, 2024 -708.39%
Dec 31, 2023 -1,087.51%
Sep 30, 2023 -697.23%
Jun 30, 2023 -865.84%
Mar 31, 2023 -2,327.23%
Dec 31, 2022 -417.90%
Sep 30, 2022 -969.40%
Jun 30, 2022 -484.94%
Mar 31, 2022 -66.46%
Dec 31, 2021 14,927.50%
Sep 30, 2021 -471.91%
Jun 30, 2021 -248.28%